Bottom line
FBIOX vs FBTAX: the short answer
FBIOX (Biotechnology Portfolio) and FBTAX (Fidelity Advisor Biotechnology Fund) share a meaningful slice of their top holdings — about 52% by weight.
FBIOX is cheaper at 0.62% vs 0.94% — a difference of $32 a year per $10,000 invested.
Over five years, FBTAX returned +6.4% a year vs +3.5% for FBIOX (reporting dates differ).
Updated Nov 19, 2026
FBIOX vs FBTAX side by side
| FBIOX | FBTAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.62% | 0.94% |
| Annual cost per $10k | $62 | $94 |
| 10-yr cost on $10k (prospectus) | $774 | $1,663 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +36.4% | +31.5% |
| 5-yr return (annualized) | +3.5% | +6.4% |
| 10-yr return (annualized) | +6.9% | +7.7% |
| Best quarter | +33.6% | +30.3% |
| Worst quarter | −28.4% | −27.8% |
| Net assets (fund) | $5.3B | $2.2B |
| Number of holdings | 215 | 129 |
| Portfolio turnover | 45% | 54% |
| Returns as of | Apr 30, 2026 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBIOX | FBTAX | Difference |
|---|---|---|---|
| 2025 | +36.4% | +39.6% | −3.2% |
| 2024 | +7.3% | +5.3% | +1.9% |
| 2023 | +10.1% | +10.7% | −0.6% |
| 2022 | −15.9% | −8.0% | −7.9% |
| 2021 | −12.4% | −3.6% | −8.8% |
| 2020 | +38.3% | +32.2% | +6.2% |
| 2019 | +36.0% | +25.7% | +10.3% |
| 2018 | −10.7% | −3.8% | −7.0% |
| 2017 | +27.9% | +25.8% | +2.1% |
| 2016 | −23.7% | −23.6% | −0.1% |
Source: Fund prospectus bar charts
Holdings overlap
13 of FBIOX's top 25 holdings also appear in FBTAX's top 25.
| Holding | FBIOX | FBTAX |
|---|---|---|
| Abbvie Inc | 9.22% | 14.71% |
| Amgen Inc | 6.53% | 2.37% |
| Gilead Sciences Inc | 4.82% | 5.70% |
| Fidelity Revere Street Trust | 3.35% | 1.96% |
| Alnylam Pharmaceuticals Inc | 2.93% | 3.62% |
| Insmed Inc | 2.25% | 3.05% |
| Argenx Se | 2.25% | 3.00% |
| Ascendis Pharma A/s | 2.04% | 2.99% |
| Revolution Medicines Inc | 2.02% | 3.00% |
| Natera Inc | 1.41% | 1.43% |
| Moderna Inc | 1.28% | 1.60% |
| Biogen Inc | 1.26% | 2.71% |
| Cogent Biosciences Inc | 1.07% | 3.25% |
Source: SEC Form N-PORT
FBIOX top 10
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Praxis Precision Medicines Inc. — 2.47%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
FBTAX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
FAQ
What is the difference between FBIOX and FBTAX?
Which is cheaper, FBIOX or FBTAX?
Should I own both FBIOX and FBTAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.